NCT05235425

Brief Summary

This research will test whether a standard version or very low-carbohydrate version of the Diabetes Prevention Program better improves outcomes like blood glucose control and body weight for patients with prediabetes. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor. Once these enrollment steps are completed and the participants will be randomized to one of two groups: standard National Diabetes Prevention Program (NDPP) or a very low-carbohydrate version. In addition to the diet (12 months) participants will be asked to participate in hour-long weekly group classes over zoom. After four months in the program, classes will occur about every month to help participants maintain the new diet. There will also be check-ins and follow-up visits through out the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
304

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 11, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

March 20, 2022

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2025

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

3.7 years

First QC Date

February 2, 2022

Last Update Submit

December 17, 2025

Conditions

Keywords

Very low carbohydrate dietDiabetes Prevention ProgramNutrition therapy

Outcome Measures

Primary Outcomes (1)

  • Change in HbA1c

    HbA1c levels will be measured by standard immunoturbidimetric assay methods and quality control measures at a Clinical Laboratory Improvement Amendments (CLIA) certified lab.

    0 to 12 months

Secondary Outcomes (7)

  • Change in Inflammation based on C-reactive protein (CRP)

    0 to 12 months

  • Change in percent body weight loss

    0-12 months

  • Change in glycemic variability

    0 to 12 months

  • Change in small particle low-density lipoproteins (LDL)

    0 to 12 months

  • Change in high-density lipoproteins (HDL)

    0 to 12 months

  • +2 more secondary outcomes

Study Arms (2)

Standard NDPP

ACTIVE COMPARATOR

12-month long, calorie-restricted NDPP

Behavioral: Standard NDPP

Very low-carbohydrate diet (VLCD)

EXPERIMENTAL

VLCD is an adaptation of the standard NDPP curriculum, which preserves all features with the exception of altered dietary advice.

Behavioral: Very low-carbohydrate diet

Interventions

Standard NDPPBEHAVIORAL

Participants in this arm will be taught to manage their prediabetes with the Centers for Disease Control's standard National Diabetes Prevention Program. It teaches a lower calorie, lower fat diet. There will be a core phase and a maintenance phase of this study; the core phase will last for about 4 months and will involve weekly or every other week classes, home assignments, and brief check-in surveys. The maintenance phase will last for the remaining time, with classes and check-in surveys approximately once a month.

Standard NDPP

Participants in this arm will be taught to manage their prediabetes with the Centers for Disease Control's National Diabetes Prevention Program, adapted to teach a very low-carbohydrate diet, also called a ketogenic or "keto" diet. This diet involves eating non-starchy vegetables, leafy greens, cheese, meats, berries, nuts, and seeds and avoiding starchy foods like pasta, bread, rice, beans, many fruits, etc. There will be a core phase and a maintenance phase of this study; the core phase will last for about 4 months and will involve weekly or every other week classes, home assignments, and brief check-in surveys. The maintenance phase will last for the remaining time, with classes and check-in surveys approximately once a month.

Very low-carbohydrate diet (VLCD)

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • overweight, defined as BMI \>= 25 kg/m2 \>= 23 kg/m2 if of Asian descent
  • HbA1c between 5.7% - 6.4% verified at baseline
  • willingness to participate in group-based sessions
  • able to engage in at least light physical activities such as walking
  • willingness to follow a prescribed diet, be randomized, self-weight, track diet, and report physical activity minutes
  • physician approval to participate

You may not qualify if:

  • history of type 1 diabetes or type 2 diabetes
  • use of anti-obesity medications or participation in another weight loss program or intervention
  • use of glucose lowering medications other than metformin
  • pregnant or planning to become pregnant during the intervention period
  • breastfeeding
  • use of oral corticosteroids
  • previous bariatric surgery or planning to have bariatric surgery during the study period
  • blood disorders that influence HbA1c, including frequent blood transfusions, phlebotomy, anemia, hemoglobinopathy, polycythemia
  • any condition for which the study team deems participation to be unsafe or inappropriate
  • inability to read, write, or speak English
  • inability to provide informed consent
  • adherence to a vegan or vegetarian diet
  • adherence to a very low-carbohydrate (keto) diet
  • difficulty chewing or swallowing
  • no influence over what foods are purchased, prepared, and/or served
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Related Publications (1)

  • Griauzde DH, O'Brien A, Yancy WS Jr, Richardson CR, Krinock J, DeJonckheere M, Isaman DJM, Vanias K, Shopinski S, Saslow LR. Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial. Trials. 2022 Sep 30;23(1):827. doi: 10.1186/s13063-022-06770-3.

MeSH Terms

Conditions

Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Laura Saslow, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessment and data analysis will be masked
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 2, 2022

First Posted

February 11, 2022

Study Start

March 20, 2022

Primary Completion

November 14, 2025

Study Completion

November 14, 2025

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations